Serial 97347411
Live / Applied — Statement of use — non-final action mailed (as of 14 Oct 2025)
What this means for you
Not registered yet, but its 05 Apr 2022 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97347411
- Mark type
- Design / logo
- Filed
- 05 Apr 2022
- Published for opposition
- 15 Nov 2022
- Attorney of record
- Steven M. Forte
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment and alleviation of disorders of the central nervous system; Pharmaceutical preparations for the treatment and alleviation of migraine headaches; Pharmaceutical preparations for the treatment and alleviation of agitation and aggression; Pharmaceutical preparations for the treatment and alleviation of Parkinson's disease
- Class 010 — Medical apparatus: Drug delivery systems, namely, inhalers for medical use; dosing aids and apparatus for medicines, namely, drug delivery and dispensing devices and systems being inhalers for medical use; nasal, respiratory, and sinus drug delivery devices and parts therefor, namely, inhalers for medical use
- Class 035 — Advertising and business services: Providing information regarding patient assistance programs, namely, discount programs for enabling participants to obtain discounts on prescription drugs through enrollment with participating pharmacies
- Class 042 — Scientific and technological services: Biomedical research services; Research and development of new products for medicinal use for others; Development and testing of pharmaceutical products and drug delivery technology; Consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; Pharmaceutical drug development; Drug development services in the fields of developing drug dosage and drug dosage form, drug delivery technologies, drug analytical methods, drug manufacturing research, drug packaging design, drug labeling design, and drug stability evaluations, storage design, and testing
- Class 044 — Medical, beauty and agricultural services: Providing information regarding patient assistance programs, namely, information relating to diagnostic and therapeutic properties of pharmaceuticals and dispensing pharmaceuticals and medical treatment
Owner
- WOODWARD SPECIALTY LLC, BAYAMON, PR, US
- WOODWARD SPECIALTY, GUAYNABO, PR, US
- JN BIDCO LLC, BAYAMON, PR, US
- IMPEL PHARMACEUTICALS INC., SEATTLE, WA, US
- IMPEL PHARMACEUTICALS INC., SEATTLE, WA, US
- Impel NeuroPharma, Inc., Seattle, WA, US
Prosecution history
- 13 Jan 2026 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
- 13 Jan 2026 — APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
- 14 Oct 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 14 Oct 2025 — NON-FINAL ACTION E-MAILED
- 14 Oct 2025 — SU - NON-FINAL ACTION - WRITTEN
- 19 Sept 2025 — STATEMENT OF USE PROCESSING COMPLETE
- 09 Jul 2025 — USE AMENDMENT FILED
- 29 Aug 2025 — RESPONSE TO ITU OFFICE ACTION ENTERED
- 29 Aug 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 15 Aug 2025 — ITU OFFICE ACTION ISSUED FOR STATEMENT OF USE
- 09 Jul 2025 — TEAS STATEMENT OF USE RECEIVED
- 09 Jul 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 09 Jul 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 09 Jul 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 09 Jul 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED